Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi’s Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi’s Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya

Purpose: Kaposi’s sarcoma (KS) is a spindle cell tumor resulting from growth dysregulation in the setting of infection with human herpes virus-8 (also called KS herpes virus). Advanced KS is characterized by poor responses to antiretroviral therapy and some of the chemotherapy readily accessible to...

Full description

Bibliographic Details
Main Authors: Naftali W. Busakhala, Paul J. Waako, Matthew Robert Strother, Alfred Kipyegon Keter, Gabriel Kimutai Kigen, Fredrick Chite Asirwa, Patrick J. Loehrer
Format: Article
Language:English
Published: American Society of Clinical Oncology 2018-01-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.17.00077

Internet

http://ascopubs.org/doi/10.1200/JGO.17.00077

Similar Items